Tuesday, January 17, 2012

FDA Says Drug Shortages Raise Risk of Cancer Counterfeits

The FDA published this notice. Looks like drug shortages are opening doors for bad actors to take advantage of the situation.

FDA Notifies Health Care Providers about the Risks of Purchasing Unapproved Injectable Cancer Medications from Unlicensed Sources
Current shortages of injectable cancer medications may present an opportunity for unscrupulous individuals to introduce non-FDA approved products into the drug supply, which could result in serious harm to patients. Health care providers are reminded to obtain and use only FDA-approved injectable cancer medications purchased directly from the manufacturer or from wholesale distributors licensed in the United States (U.S.).
'via Blog this'

Return Home: The Health, Drug, Prescription, and GMP Supersite Blog

GMP Posters by SkillsPlus Intl Inc.
SkillsPlus Intl Inc. - GMP Compliance Training Experts
SkillsPlus Intl Info Blog
The Health, Drug, Prescription, and GMP Supersite Gift Store 

No comments:

From SkillsPlus International Inc.

Custom Search

Even More Resources, Books, & Things (many from Amazon.com)

FDA, GMPs, QSR, GCP, GLP, GXP:
    GMP Training Gifts & Giveaways